JP5259226B2 - Reagent for control sample preparation - Google Patents

Reagent for control sample preparation Download PDF

Info

Publication number
JP5259226B2
JP5259226B2 JP2008089039A JP2008089039A JP5259226B2 JP 5259226 B2 JP5259226 B2 JP 5259226B2 JP 2008089039 A JP2008089039 A JP 2008089039A JP 2008089039 A JP2008089039 A JP 2008089039A JP 5259226 B2 JP5259226 B2 JP 5259226B2
Authority
JP
Japan
Prior art keywords
hemoglobin
glucose
measurement
control sample
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008089039A
Other languages
Japanese (ja)
Other versions
JP2009240190A (en
Inventor
和之 大石
俊樹 川辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Medical Co Ltd
Original Assignee
Sekisui Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd filed Critical Sekisui Medical Co Ltd
Priority to JP2008089039A priority Critical patent/JP5259226B2/en
Publication of JP2009240190A publication Critical patent/JP2009240190A/en
Application granted granted Critical
Publication of JP5259226B2 publication Critical patent/JP5259226B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

本発明は、グルコースおよび/またはヘモグロビンA1cの測定を行なう際に用いられる管理試料を調製するための試薬に関する。   The present invention relates to a reagent for preparing a control sample used for measuring glucose and / or hemoglobin A1c.

糖尿病検査のマーカーとしては、グルコース(血糖値)、糖化ヘモグロビン、糖化アルブミンなどが知られている。特に糖化ヘモグロビンの1種であるヘモグロビンA1cは、HPLC法、電気泳動法、酵素法、免疫法などによる測定方法が確立されており、臨床検査の分野において測定されている。検査の精度を向上させるためには、複数のマーカーの測定がよいとされており、特にヘモグロビンA1cとグルコース(血糖値)の連続測定あるいは同時測定は有益である。   Known markers for diabetes testing include glucose (blood glucose level), glycated hemoglobin, glycated albumin and the like. In particular, hemoglobin A1c, which is one type of glycated hemoglobin, has been established by HPLC, electrophoresis, enzyme, immunoassay, and the like, and is measured in the field of clinical examination. In order to improve the accuracy of the test, measurement of a plurality of markers is considered good. In particular, continuous measurement or simultaneous measurement of hemoglobin A1c and glucose (blood glucose level) is beneficial.

各マーカーの測定時には、測定対象となるマーカー物質を、既知量含む管理試料を用いたキャリブレーションなどの較正・補正操作が必要である。管理試料に関する技術としては、いろいろな技術が開示されている(特許文献1および特許文献2など)。
特開2005−181128号公報 特開平10−017597号公報
When measuring each marker, a calibration / correction operation such as calibration using a control sample containing a known amount of the marker substance to be measured is required. Various techniques relating to the control sample have been disclosed (Patent Document 1 and Patent Document 2).
Japanese Patent Application Laid-Open No. 2005-181128 Japanese Patent Laid-Open No. 10-017597

現在は、各糖尿病マーカー毎に、別個の管理試料が市販されており、複数の糖尿病マーカーを測定する際には、各管理試料による個別の管理が必要である。例えばグルコース測定時には、既知量のグルコースを含有する管理試料の測定による管理、ヘモグロビンA1cを測定する場合には、既知量のヘモグロビンA1cを含有する管理試料の測定による管理が、別個に必要であった。
またこのような管理試料の測定による操作は、高精度の検査精度を維持するために、所定の頻度での測定が必要であるが、各管理試料は非常に高額であるため、使用量が抑えられる傾向にあり、管理レベルの低下による測定精度の低下が懸念されている。
Currently, separate management samples are commercially available for each diabetes marker, and when measuring a plurality of diabetes markers, individual management by each management sample is required. For example, when measuring glucose, management by measurement of a management sample containing a known amount of glucose, and when measuring hemoglobin A1c, management by measurement of a management sample containing a known amount of hemoglobin A1c was separately required. .
In addition, such operation by measurement of the control sample requires measurement at a predetermined frequency in order to maintain high accuracy of inspection, but each control sample is very expensive, so the usage amount is suppressed. There is a concern that the measurement accuracy will decrease due to a decrease in the management level.

グルコースおよびヘモグロビンA1cの両者を含む管理試料があれば、両者を測定する際のコスト低減に有益である。また両者の同時測定法であれば、両者を含む管理試料により1回の測定で管理が可能となり、操作の時間短縮も可能となる。
しかし、ヘモグロビンA1cは、グルコースとヘモグロビンとの反応物であるため、グルコースとヘモグロビンA1cを共存させて管理試料とした場合、保存時に両者が反応して、グルコースおよびヘモグロビンA1cの濃度が変化してしまうという欠点があった。
If there is a control sample containing both glucose and hemoglobin A1c, it is beneficial for cost reduction when measuring both. Further, if both methods are simultaneously measured, management can be performed by a single measurement using a management sample including both, and the operation time can be shortened.
However, since hemoglobin A1c is a reaction product of glucose and hemoglobin, when glucose and hemoglobin A1c coexist as a control sample, both react to each other during storage, and the concentrations of glucose and hemoglobin A1c change. There was a drawback.

本発明の目的は、糖尿病診断の指標となるグルコースおよび/またはヘモグロビンA1cを測定する際に共通して用いることができる管理試料を、容易に調製するための試薬を提供することにある。   An object of the present invention is to provide a reagent for easily preparing a control sample that can be used in common when measuring glucose and / or hemoglobin A1c, which is an index for diagnosis of diabetes.

そこで本発明者らは、グルコース測定とヘモグロビンAlc測定に共通して用いることのできる管理試料の調製について検討したところ、従来用いられているヘモグロビンA1c測定用管理試料を調製するために用いられる調製用試薬に、既知量のグルコースを含有させておくことにより、従来のヘモグロビンA1c測定用管理試料を調製方法と同様の手法により、容易にグルコース測定およびヘモグロビンA1c測定に共通して用いることのできる管理試料を調製できることを見出した。   Therefore, the present inventors examined the preparation of a control sample that can be used in common for glucose measurement and hemoglobin Alc measurement, and as a result, the preparation used for preparing a control sample for hemoglobin A1c measurement that has been conventionally used By including a known amount of glucose in the reagent, a management sample for conventional hemoglobin A1c measurement can be easily used in common for glucose measurement and hemoglobin A1c measurement by the same method as the preparation method. It was found that can be prepared.

すなわち本発明は、グルコースおよび/またはヘモグロビンA1cの測定に用いられる管理試料を調製するための試薬であって、最終濃度が10〜1000mg/dLの範囲内となる既知量のグルコースを含有することを特徴とする、管理試料調製用試薬を提供するものである。   That is, the present invention is a reagent for preparing a control sample used for measurement of glucose and / or hemoglobin A1c, and contains a known amount of glucose having a final concentration in the range of 10 to 1000 mg / dL. A feature of the present invention is to provide a management sample preparation reagent.

本発明の管理試料調製用試薬を用いた場合、公知のヘモグロビンA1c測定用管理試料をそのまま使用して、公知のグルコースおよび/またはヘモグロビンA1cの測定方法の管理が可能である。また両者の測定に共通して管理試料を用いることができるため、コスト的に有利である。また測定直前に両者が混合されるため、両者共存による両者の含有量の変動もない。   In the case of using the management sample preparation reagent of the present invention, it is possible to manage a known glucose and / or hemoglobin A1c measurement method by using a known hemoglobin A1c measurement management sample as it is. Moreover, since a control sample can be used in common for both measurements, it is advantageous in terms of cost. Moreover, since both are mixed immediately before a measurement, both content does not fluctuate by both coexistence.

本発明の管理試料調製用試薬は、最終濃度が10〜1000mg/dLの範囲内となる既知量のグルコースを含有する溶液よりなる。
本発明の管理試料調製用試薬に含有されるグルコースは、特に制限がなく、本発明の管理試料調製用試薬により調製された管理試料を用いて測定されるグルコースの測定方法において、本管理試料が測定対象試料と同様に測定が可能であるグルコースであればよい。より好ましくは、現行のグルコース測定用管理試料に用いられる高純度グルコース等の高純度品である。
The control sample preparation reagent of the present invention comprises a solution containing a known amount of glucose with a final concentration in the range of 10 to 1000 mg / dL.
The glucose contained in the management sample preparation reagent of the present invention is not particularly limited. In the glucose measurement method using the management sample prepared by the management sample preparation reagent of the present invention, Any glucose that can be measured in the same manner as the sample to be measured may be used. More preferably, it is a high-purity product such as high-purity glucose used for the current glucose measurement management sample.

本発明の管理試料調製用試薬に含有されるグルコースの濃度は、最終濃度が10〜1000mg/dLの範囲内となる濃度であれば特に制限はない。
上記の最終濃度とは、後述するヘモグロビンA1c用管理試料に添加して希釈された際の濃度である。例えば、ヘモグロビンA1c管理試料0.2mLに、本発明の管理試料調製用試薬2.0mLを添加して、最終濃度100mg/dLのグルコースを含有するグルコースおよび/またはヘモグロビンA1c測定用管理試料を調製する場合、本発明の管理調製用試薬には110mg/dLのグルコースを含有させておけばよい。
上記範囲外のグルコースの最終濃度は、健常人試料および多くの糖尿病患者試料の測定値の範囲から逸脱するため、グルコースの測定系における管理試料による補正または較正などができにくく好ましくない。
The concentration of glucose contained in the control sample preparation reagent of the present invention is not particularly limited as long as the final concentration is within the range of 10 to 1000 mg / dL.
The above final concentration is the concentration when diluted by adding to a hemoglobin A1c management sample described later. For example, 2.0 mL of the management sample preparation reagent of the present invention is added to 0.2 mL of hemoglobin A1c management sample to prepare glucose and / or hemoglobin A1c measurement management sample containing glucose at a final concentration of 100 mg / dL. In this case, the management preparation reagent of the present invention may contain 110 mg / dL of glucose.
Since the final concentration of glucose outside the above range deviates from the range of measurement values of healthy human samples and many diabetic patient samples, it is not preferable because correction or calibration by a control sample in a glucose measurement system is difficult.

また本発明の管理調製用試薬を用いて調製された管理試料をグルコースおよび/またはヘモグロビンA1cの測定に供する場合、1種のまたは2種以上の既知濃度の管理試料を複数種調製して測定に供してもよい。2種以上の濃度の管理試料を調製する場合には、当該濃度のグルコースを含有する管理試料調整用試薬を複数用意して調製すればよい。複数の既知濃度の管理試料として供される場合であっても、全ての管理試料調整用試薬のグルコース濃度は、最終濃度が10〜1000mg/dLの範囲内である必要がある。   In addition, when a control sample prepared using the control preparation reagent of the present invention is used for measurement of glucose and / or hemoglobin A1c, a plurality of control samples having one or more known concentrations are prepared for measurement. May be provided. When preparing a control sample having two or more concentrations, a plurality of control sample adjusting reagents containing glucose at the concentration may be prepared and prepared. Even when provided as a plurality of control samples having known concentrations, the glucose concentration of all control sample preparation reagents needs to have a final concentration in the range of 10 to 1000 mg / dL.

本発明の管理試料調製用試薬は、上記濃度のグルコースを含むこと以外に特に制限はなく、試薬のpH、組成等の制限はない。後述する本発明の管理試料調製用試薬により得られた管理試料が、測定試料と同等の測定ができればよい。好ましくは、グルコースを既知濃度含む水溶液または緩衝液である。必要に応じて防腐剤等の安定化作用を有する物質、ポリオキシエチレンアルキルフェニルエーテルなどの溶血作用を有する界面活性剤等を添加してもよい。
緩衝液とする場合は、本発明の管理試料調製用試薬により得られた管理試料を測定する場合に測定の阻害とならない組成および物性であればよい。また測定系に用いられる緩衝液と同一あるいは類似の緩衝液としてもよい。当該緩衝液としては、pH4.0〜10.0、さらにpH5.0〜9.0の範囲で緩衝能を有する緩衝剤を含有する緩衝液が好ましい。このような緩衝剤としては、クエン酸、コハク酸、酒石酸、リンゴ酸等の有機酸及びその塩類;グリシン、タウリン、アルギニン等のアミノ酸類;塩酸、硝酸、硫酸、リン酸、ホウ酸、酢酸等の無機酸及びその塩類等、グッドの緩衝液などの両性緩衝液が挙げられる。
The reagent for preparing a control sample of the present invention is not particularly limited except that it contains glucose at the above concentration, and there are no restrictions on the pH, composition, etc. of the reagent. It is only necessary that the management sample obtained by the management sample preparation reagent of the present invention described later can perform the same measurement as the measurement sample. Preferably, it is an aqueous solution or buffer solution containing a known concentration of glucose. If necessary, a substance having a stabilizing action such as a preservative, a surfactant having a hemolytic action such as polyoxyethylene alkylphenyl ether, and the like may be added.
In the case of using a buffer solution, any composition and physical properties that do not hinder measurement when measuring a control sample obtained by the control sample preparation reagent of the present invention may be used. Moreover, it is good also as a buffer solution same as or similar to the buffer solution used for a measurement system. As the buffer solution, a buffer solution containing a buffering agent having a buffer capacity in the range of pH 4.0 to 10.0, and further pH 5.0 to 9.0 is preferable. Examples of such buffers include organic acids such as citric acid, succinic acid, tartaric acid and malic acid and salts thereof; amino acids such as glycine, taurine and arginine; hydrochloric acid, nitric acid, sulfuric acid, phosphoric acid, boric acid and acetic acid. And amphoteric buffer solutions such as Good's buffer solution.

本発明の管理試料調製用試薬により調製される管理試料は、管理に適した既知量のヘモグロビンA1cを含有するヘモグロビン含有試料である。好ましい管理に適したヘモグロビンA1c濃度は3〜15%である。上記範囲を逸脱するヘモグロビンA1c濃度を有するヘモグロビン含有試料は、通常の検査における健常人および糖尿病患者の測定値から外れるため、管理試料として用いるには相応しくない。また上記ヘモグロビン含有試料は、溶液であっても、凍結乾燥品であってもよい。上記ヘモグロビン含有試料として、現在ヘモグロビンA1cを測定する際の管理に用いられている、公知の標準試料を用いることができる。すなわち、HPLC法、電気泳動法、免疫法、酵素法等によるヘモグロビンA1cの測定時における管理試料として用いられる、ヒト血液由来の、既知量のヘモグロビンA1cを既知量含むヘモグロビン含有試料を用いることができる。   The management sample prepared by the management sample preparation reagent of the present invention is a hemoglobin-containing sample containing a known amount of hemoglobin A1c suitable for management. The hemoglobin A1c concentration suitable for preferable management is 3 to 15%. A hemoglobin-containing sample having a hemoglobin A1c concentration that deviates from the above range is not suitable for use as a management sample because it deviates from the measurement values of healthy persons and diabetic patients in a normal examination. The hemoglobin-containing sample may be a solution or a lyophilized product. As the hemoglobin-containing sample, a known standard sample that is currently used for management when measuring hemoglobin A1c can be used. That is, a hemoglobin-containing sample containing a known amount of hemoglobin A1c derived from human blood, which is used as a control sample when measuring hemoglobin A1c by HPLC, electrophoresis, immunization, enzyme method, or the like can be used. .

本発明の管理試料調製用試薬は、グルコースおよびヘモグロビンA1cの両者を同時に、または連続して測定する場合に特に有効である。またグルコースのみの測定もしくは、ヘモグロビンA1cのみの測定に用いることもできる。   The reagent for preparing a control sample of the present invention is particularly effective when measuring both glucose and hemoglobin A1c simultaneously or successively. It can also be used for measuring only glucose or measuring only hemoglobin A1c.

本発明の管理試料調製用試薬による管理試料の調製は、測定の直前に行なわれることが好ましい。具体的には、本発明の管理試料調製用試薬による管理試料の調製が行なわれてから24時間以内に測定が行なわれることが好ましい。調製後24時間以上経過した場合は、管理試料内において、ヘモグロビンとグルコースが反応して、グルコース濃度およびヘモグロビンA1c値が変動し、精度管理に支障を来たす恐れが生じる。より好ましくは調製後、12時間以内に測定が行なわれる必要がある。
一般に現行のヘモグロビンA1cの測定方法に用いられている管理試料の調製においても、通常は測定直前に行なわれるため、本発明の試薬による調製方法も同様である。
The management sample is preferably prepared by the management sample preparation reagent of the present invention immediately before the measurement. Specifically, the measurement is preferably performed within 24 hours after the preparation of the control sample using the control sample preparation reagent of the present invention. When 24 hours or more have elapsed after preparation, hemoglobin reacts with glucose in the control sample, and the glucose concentration and hemoglobin A1c value fluctuate, which may impair accuracy control. More preferably, the measurement needs to be performed within 12 hours after preparation.
In general, the preparation of the control sample used in the current method for measuring hemoglobin A1c is usually performed immediately before the measurement, and therefore the preparation method using the reagent of the present invention is also the same.

本発明の管理試料調製用試薬により調製された管理試料を用いたグルコースの測定方法は特に制限はなく、公知の方法が用いられる。好ましくはヘキソキナーゼ、グルコースオキシダーゼ、グルコースでヒドロゲナーゼ、グルコキナーゼなどの酵素を用いた方法、およびこれらの酵素を固定化した固定化酵素を用いる方法、または酵素電極を用いた方法である。好ましくはグルコースオキシダーゼを用いた酵素電極法である。   The method for measuring glucose using the control sample prepared by the control sample preparation reagent of the present invention is not particularly limited, and a known method is used. Preferred are a method using an enzyme such as hexokinase, glucose oxidase, glucose hydrogenase, glucokinase, a method using an immobilized enzyme in which these enzymes are immobilized, or a method using an enzyme electrode. The enzyme electrode method using glucose oxidase is preferable.

また本発明の管理試料調製用試薬により調製された糖尿病検査用管理試料を用いた、ヘモグロビンA1cの測定方法としては、特に制限はなく、公知の方法が用いられる。好ましくはHPLC法、酵素法、電気泳動法、免疫法などが挙げられる。特に好ましくはHPLC法、酵素法である。
本発明の管理試料調製用試薬により調製された管理試料を用いれば、グルコースおよび/またはヘモグロビンA1cが測定できる。
Moreover, there is no restriction | limiting in particular as a measuring method of hemoglobin A1c using the management sample for diabetes tests prepared with the management sample preparation reagent of this invention, A well-known method is used. Preferably, HPLC method, enzyme method, electrophoresis method, immunization method and the like can be mentioned. Particularly preferred are HPLC and enzymatic methods.
By using the control sample prepared by the control sample preparation reagent of the present invention, glucose and / or hemoglobin A1c can be measured.

さらに本発明の管理試料調製用試薬により調製された管理試料を用いて、グルコースおよびヘモグロビンA1cを連続に、または同時に測定してもよい。例えば、酵素法によるグルコース測定装置とHPLC法によるヘモグロビンA1c(グルコース以外の糖尿病マーカー)測定装置を搬送装置で連結した測定装置や、酵素法によるグルコースおよびヘモグロビンA1cの同時測定法が開示されているが、本発明の管理試料調製用試薬により調製された管理試料を用いて、これらの測定装置による連続または同時測定法を行なうことができる。これらの連続測定法や同時測定法の場合、それぞれの測定法の原理に制限はなく、公知の測定法を組み合わせて測定することができる。
本発明の管理試料調製用試薬により調製された管理試料は、グルコースおよびヘモグロビンA1cの連続測定法または同時測定法に特に有用である。
Furthermore, glucose and hemoglobin A1c may be measured continuously or simultaneously using the control sample prepared by the control sample preparation reagent of the present invention. For example, a measuring device in which a glucose measuring device by an enzyme method and a hemoglobin A1c (diabetic marker other than glucose) measuring device by an HPLC method are connected by a transport device, and a simultaneous measuring method of glucose and hemoglobin A1c by an enzymatic method are disclosed. Using the control sample prepared with the control sample preparation reagent of the present invention, a continuous or simultaneous measurement method using these measuring devices can be performed. In the case of these continuous measurement methods and simultaneous measurement methods, the principle of each measurement method is not limited, and measurement can be performed by combining known measurement methods.
The control sample prepared by the control sample preparation reagent of the present invention is particularly useful for the continuous measurement method or simultaneous measurement method of glucose and hemoglobin A1c.

次に実施例を挙げて、本発明をさらに詳細に説明するが、本発明はこれに何ら限定されるものではない。   EXAMPLES Next, although an Example is given and this invention is demonstrated further in detail, this invention is not limited to this at all.

(実施例1)
グルコース(NIST標準品:HECTEF製SRM917)を77mg/dLおよび0.01%のTritonX−100(和光純薬製:界面活性剤)を含む50mMリン酸緩衝液(pH7.0)に溶解して管理試料調製用試薬を調製した。
ヘモグロビンA1c測定用管理試料(シスメックス製グリコHbコントロール:ヘモグロビンA1c値が5.0%)1バイアルに、0.2mLの蒸留水を添加して溶解した後、得られた上記溶解液0.2mLに対して上記管理試料調製用試薬2mLを添加して、グルコース最終濃度70mg/dLおよびヘモグロビンA1c5.0%を含有する、グルコースおよびヘモグロビンA1c測定用管理試料を調製した。
また同様に、グルコース143mg/dLを含む管理試料調製用試薬を調製し、管理試料(同:ヘモグロビンA1c値が11.0%)に添加して、グルコース最終濃度130mg/dLおよびヘモグロビンA1c11.0%を含有する管理試料を調製した。
Example 1
Glucose (NIST standard: HECTEF SRM917) dissolved in 50 mM phosphate buffer (pH 7.0) containing 77 mg / dL and 0.01% Triton X-100 (Wako Pure Chemicals: Surfactant) A sample preparation reagent was prepared.
Control sample for hemoglobin A1c measurement (Glyco Hb control manufactured by Sysmex: hemoglobin A1c value is 5.0%) 1 vial was dissolved by adding 0.2 mL of distilled water, and then 0.2 mL of the resulting solution was added to 0.2 mL On the other hand, 2 mL of the reagent for preparing the control sample was added to prepare a control sample for measuring glucose and hemoglobin A1c containing a final glucose concentration of 70 mg / dL and hemoglobin A1c 5.0%.
Similarly, a reagent for preparing a control sample containing 143 mg / dL of glucose is prepared and added to the control sample (the same: hemoglobin A1c value is 11.0%) to obtain a final glucose concentration of 130 mg / dL and hemoglobin A1c of 11.0%. A control sample containing was prepared.

上記で得られた2種類の管理試料を、グルコース測定装置およびヘモグロビンA1c測定装置にて測定した。測定装置として、グルコース測定装置(アークレイ製GA−1170:酵素電極法)およびヘモグロビンA1c測定装置(アークレイ製HA−8170:HPLC法)を用いた。   The two types of control samples obtained above were measured with a glucose measuring device and a hemoglobin A1c measuring device. As a measuring device, a glucose measuring device (ARKRAY GA-1170: enzyme electrode method) and a hemoglobin A1c measuring device (ARKRAY HA-8170: HPLC method) were used.

測定の結果得られた各数値を、基準値、すなわちグルコース濃度がそれぞれ70mg/dLおよび130mg/dL、ヘモグロビンA1c値がそれぞれ5.0%および11.0%となるよう補正式を算出した。
上記管理試料の測定に引き続き、健常人および糖尿病患者よりフッ化ナトリウム採血して得られた測定試料を、各測定装置の定法によって測定した。得られた測定試料の測定値を上記補正式に代入して補正値を算出した。得られた結果を表1に示す。
The correction formula was calculated so that each numerical value obtained as a result of the measurement was a reference value, that is, a glucose concentration of 70 mg / dL and 130 mg / dL, respectively, and a hemoglobin A1c value of 5.0% and 11.0%, respectively.
Subsequent to the measurement of the control sample, a measurement sample obtained by collecting sodium fluoride from healthy subjects and diabetic patients was measured by a conventional method of each measuring device. The correction value was calculated by substituting the measurement value of the obtained measurement sample into the correction equation. The obtained results are shown in Table 1.

(実施例2)
グルコース測定装置として、クリニカルアナライザS40(第一化学薬品製:ヘキソキナーゼ法)、ヘモグロビンA1c測定装置として日立7170型自動分析装置(ノルディアHbA1c:第一化学薬品製:酵素法)を用いた以外は、上記実施例1と同様の操作により同一試料を測定した。得られた結果(補正値)を表1に示す。
(Example 2)
The above except that the clinical analyzer S40 (manufactured by Daiichi Chemicals: hexokinase method) was used as the glucose measuring device, and the Hitachi 7170 automatic analyzer (Nordia HbA1c: manufactured by Daiichi Chemicals: enzymatic method) was used as the hemoglobin A1c measuring device. The same sample was measured by the same operation as in Example 1. The obtained results (correction values) are shown in Table 1.

(実施例3)
グルコースおよびヘモグロビンA1c測定装置として特開2007−155684号公開の装置(王子計測器製BF−3Tを改良、グルコースおよびヘモグロビンA1c共に酵素法)を用いた。上記実施例1と同様の操作により同一試料を測定した。得られた結果(補正値)を表1に示す。
(Example 3)
As an apparatus for measuring glucose and hemoglobin A1c, an apparatus disclosed in Japanese Patent Application Laid-Open No. 2007-155684 (improved BF-3T manufactured by Oji Scientific Instruments, and an enzymatic method for both glucose and hemoglobin A1c) was used. The same sample was measured by the same operation as in Example 1 above. The obtained results (correction values) are shown in Table 1.

Figure 0005259226
Figure 0005259226

表1に示す通り、本発明の管理試料調製用試薬を用いて補正を行なった結果、測定値が同一となり、グルコースおよびヘモグロビンA1c値の補正が可能であることが示された。すなわち本発明の管理試料調製用試薬により調製された管理試料は、グルコースおよびヘモグロビンA1cの測定の両者に共通して用いることができることが確認された。   As shown in Table 1, as a result of performing the correction using the control sample preparation reagent of the present invention, the measured values became the same, indicating that the glucose and hemoglobin A1c values can be corrected. That is, it was confirmed that the control sample prepared by the control sample preparation reagent of the present invention can be used in common for both measurement of glucose and hemoglobin A1c.

Claims (5)

糖尿病診断の指標となるヘモグロビンAlcおよびグルコースの測定に共通して用いられる管理試料を調製するための試薬であって、最終濃度が10〜1000mg/dLの範囲内となる既知量のグルコースを含有し、測定の24時間前以内に、既知量のヘモグロビンAlcを含有するヘモグロビン含有試料と混合して使用されるものである管理試料調製用試薬。 A reagent for preparing a control sample commonly used for measurement of hemoglobin Alc and glucose, which is an index for diagnosis of diabetes , and containing a known amount of glucose with a final concentration in the range of 10 to 1000 mg / dL , 24 hours prior within, der Ru manage sample preparation reagents shall be used as a mixture with hemoglobin containing samples containing known amounts of hemoglobin Alc measurement. 既知量のヘモグロビンAlc濃度が3〜15%である請求項記載の管理試料調製用試薬。 Control sample preparation reagent according to claim 1 hemoglobin Alc concentration a known amount of 3 to 15%. 糖尿病診断の指標となるヘモグロビンAlc測定およびグルコース測定に共通して用いられる管理試料の調製方法であって、該測定の24時間前以内に、既知量のヘモグロビンAlcを含有するヘモグロビン含有試料に、請求項1記載の管理試料調製用試薬を添加することを含む方法。A method for preparing a control sample commonly used for hemoglobin Alc measurement and glucose measurement as an index for diagnosis of diabetes, wherein a hemoglobin-containing sample containing a known amount of hemoglobin Alc is charged within 24 hours before the measurement. A method comprising adding the reagent for preparing a control sample according to Item 1. 既知量のヘモグロビンAlc濃度が3〜15%である請求項3記載の方法。The method according to claim 3, wherein the known amount of hemoglobin Alc concentration is 3 to 15%. 請求項1もしくは2記載の管理試料調製用試薬により得られたか、または請求項3もしくは4記載の方法で調製した管理試料を用いた、グルコースおよびヘモグロビンA1cの連続測定法または同時測定法。 A continuous measurement method or simultaneous measurement method of glucose and hemoglobin A1c using the control sample obtained by the control sample preparation reagent according to claim 1 or 2 or prepared by the method according to claim 3 or 4 .
JP2008089039A 2008-03-31 2008-03-31 Reagent for control sample preparation Expired - Fee Related JP5259226B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008089039A JP5259226B2 (en) 2008-03-31 2008-03-31 Reagent for control sample preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008089039A JP5259226B2 (en) 2008-03-31 2008-03-31 Reagent for control sample preparation

Publications (2)

Publication Number Publication Date
JP2009240190A JP2009240190A (en) 2009-10-22
JP5259226B2 true JP5259226B2 (en) 2013-08-07

Family

ID=41302888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008089039A Expired - Fee Related JP5259226B2 (en) 2008-03-31 2008-03-31 Reagent for control sample preparation

Country Status (1)

Country Link
JP (1) JP5259226B2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028542A (en) * 1990-02-07 1991-07-02 Boehringer Mannheim Corporation Glucose measurement control reagent and method of making the same
JP3686482B2 (en) * 1996-06-27 2005-08-24 株式会社ビー・エム・エル Control sample of hemoglobin A1C
US7670794B2 (en) * 2005-11-04 2010-03-02 Washington University Managing glycemia status in diabetic patients

Also Published As

Publication number Publication date
JP2009240190A (en) 2009-10-22

Similar Documents

Publication Publication Date Title
CN107076728B (en) Analytical method for diluting biological sample components
EP3321676B1 (en) Blood test kit and blood analysis method
EP2565646B1 (en) Diagnostic marker for kidney diseases and use thereof
Ising et al. Measurement of free magnesium in blood, serum and plasma with an ion-sensitive electrode
US20110165608A1 (en) Blood component measurement method utilizing hemolyzed whole blood, and kit for the method
CN112501245B (en) Novel N-acetyl-beta-D glucosaminidase detection reagent
CN114277089B (en) Detection reagent and kit for dabigatran
CN101503732A (en) Glucose oxidase single liquid detection reagent
Baumstark et al. Influence of partial pressure of oxygen in blood samples on measurement performance in glucose-oxidase-based systems for self-monitoring of blood glucose
Genter et al. Accuracy of plasma glucose measurements in the hypoglycemic range
CN104730230A (en) Enzymatic method detection kit of D-3-hydroxybutyric acid and preparation method thereof
CN106645665A (en) Thrombin time detection reagent
Temel et al. Determination of dynamic thiol/disulphide homeostasis in children with tetralogy of Fallot and ventricular septal defect
CN107290545A (en) β2-microglobulin solution, its preparation method and the application of a kind of stabilization
JP5259226B2 (en) Reagent for control sample preparation
WO2016186521A1 (en) Haemolysis stabilising composition
Morgan et al. Stability of the strong ion gap versus the anion gap over extremes of PCO2 and pH
KR20180016511A (en) Blood analysis method and blood test kit
CN113720836A (en) Kit for detecting serum copper ions and preparation method thereof
JP2010145380A (en) Method for inspecting electrode of oxidation-reduction potential measuring apparatus, and standard solution for inspecting electrode of oxidation-reduction potential measuring apparatus
CN105223192A (en) A kind of glycated serum protein detects reagent and application thereof
US20120015388A1 (en) Diluent for Preparing Analytical Sample
JP2000346848A (en) Method and apparatus for measuring glucose
CN103217525A (en) Composition for improving cystatin C latex coated antibody stability, stabilizer containing the same, preparation method and application thereof
Pleus et al. Post-market surveillance of 18 blood glucose monitoring systems' accuracy based on ISO 15197: 2013

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101015

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20101015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130327

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130424

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160502

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5259226

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees